Trang T. Ly

5.2k total citations
98 papers, 2.5k citations indexed

About

Trang T. Ly is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Trang T. Ly has authored 98 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Endocrinology, Diabetes and Metabolism, 65 papers in Surgery and 45 papers in Genetics. Recurrent topics in Trang T. Ly's work include Diabetes Management and Research (94 papers), Pancreatic function and diabetes (63 papers) and Diabetes and associated disorders (44 papers). Trang T. Ly is often cited by papers focused on Diabetes Management and Research (94 papers), Pancreatic function and diabetes (63 papers) and Diabetes and associated disorders (44 papers). Trang T. Ly collaborates with scholars based in United States, Australia and Canada. Trang T. Ly's co-authors include Timothy W. Jones, Elizabeth A. Davis, Bruce A. Buckingham, David M. Maahs, Adam Retterath, Jennifer A. Nicholas, Ee Mun Lim, Gregory P. Forlenza, Lauren M. Huyett and Paula Clinton and has published in prestigious journals such as JAMA, Diabetes Care and Diabetes.

In The Last Decade

Trang T. Ly

91 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Trang T. Ly United States	32	2.3k	1.7k	1.4k	115	114	98	2.5k
Laurel H. Messer United States	32	2.4k 1.0×	1.6k 0.9×	1.5k 1.0×	97 0.8×	203 1.8×	92	2.8k
Daniela Elleri United Kingdom	24	1.8k 0.8×	1.4k 0.8×	1.1k 0.7×	66 0.6×	104 0.9×	54	2.1k
Jennifer L. Sherr United States	32	3.1k 1.3×	2.2k 1.3×	1.9k 1.3×	92 0.8×	145 1.3×	115	3.5k
Jordan E. Pinsker United States	22	1.1k 0.5×	727 0.4×	658 0.5×	82 0.7×	97 0.9×	80	1.4k
Craig Kollman United States	27	1.8k 0.8×	1.4k 0.8×	1.2k 0.9×	111 1.0×	59 0.5×	49	2.3k
Firas H. El-Khatib United States	18	1.6k 0.7×	1.3k 0.8×	921 0.6×	67 0.6×	34 0.3×	30	1.8k
Joseph El Youssef United States	25	1.4k 0.6×	1.0k 0.6×	743 0.5×	166 1.4×	79 0.7×	53	1.7k
Ahmad Haidar Canada	27	2.0k 0.8×	1.6k 0.9×	1.1k 0.8×	97 0.8×	33 0.3×	71	2.2k
Wendy C. Bevier United States	23	1.2k 0.5×	828 0.5×	558 0.4×	135 1.2×	76 0.7×	65	1.8k
Laya Ekhlaspour United States	18	1.2k 0.5×	989 0.6×	856 0.6×	44 0.4×	52 0.5×	49	1.4k

Countries citing papers authored by Trang T. Ly

Since Specialization

Citations

This map shows the geographic impact of Trang T. Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trang T. Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trang T. Ly more than expected).

Fields of papers citing papers by Trang T. Ly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trang T. Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trang T. Ly. The network helps show where Trang T. Ly may publish in the future.

Co-authorship network of co-authors of Trang T. Ly

This figure shows the co-authorship network connecting the top 25 collaborators of Trang T. Ly. A scholar is included among the top collaborators of Trang T. Ly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trang T. Ly. Trang T. Ly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meier, Renee A., Niranjala Hewapathirana, Sandra Donnelly, et al.. (2025). EValuating Glucose ContrOL Using a Next-GeneraTION Automated Insulin Delivery Algorithm in Patients with Type 1 and Type 2 Diabetes: The EVOLUTION Study. Diabetes Technology & Therapeutics. 27(4). 323–328. 1 indexed citations

Forlenza, Gregory P., Daniel J. DeSalvo, Grazia Aleppo, et al.. (2024). Real-World Evidence of Omnipod ^® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technology & Therapeutics. 26(8). 514–525. 36 indexed citations

Nguyễn, Vũ Quốc Huy, Nguyen Minh Tam, Johan Wens, et al.. (2024). Exploring the relationships between self-efficacy, self-care, and glycaemic control in primary care diabetes management. SAGE Open Medicine. 12. 3932160832–3932160832. 1 indexed citations

DeSalvo, Daniel J., Bruce W. Bode, Gregory P. Forlenza, et al.. (2024). Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod ^® 5 Automated Insulin Delivery System. Diabetes Technology & Therapeutics. 26(6). 383–393. 12 indexed citations

Vuong, Lan N., Vu N A Ho, Hieu H. Pham, et al.. (2024). O-190 Hormone-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomised clinical trial. Human Reproduction. 39(Supplement_1). 1 indexed citations

Lal, Rayhan, et al.. (2023). 57-OR: Real-World Glycemic Outcomes of >5,900 Adults with Type 1 Diabetes Using the Omnipod 5 Automated Insulin Delivery (AID) System with Cloud-Based Data Management. Diabetes. 72(Supplement_1). 1 indexed citations

Davis, Georgia M., Michael S. Hughes, Sue A. Brown, et al.. (2023). Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial. Diabetes Technology & Therapeutics. 25(10). 677–688. 19 indexed citations

Hood, Korey K., William H. Polonsky, Sarah A. MacLeish, et al.. (2023). Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatric Diabetes. 2023. 1–12. 6 indexed citations

Pinsker, Jordan E., Mei Mei Church, Sue A. Brown, et al.. (2021). Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment. Diabetes Technology & Therapeutics. 24(1). 18–25. 6 indexed citations

10.

Sherr, Jennifer L., Bruce W. Bode, Gregory P. Forlenza, et al.. (2021). 70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D). Diabetes. 70(Supplement_1). 1 indexed citations

11.

Blevins, Thomas, Wendy Lane, David Rodbard, et al.. (2020). Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study. Diabetes Technology & Therapeutics. 23(1). 51–58. 8 indexed citations

12.

Forlenza, Gregory P., Bruce A. Buckingham, Jennifer L. Sherr, et al.. (2020). 978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).

13.

Sherr, Jennifer L., Bruce A. Buckingham, Gregory P. Forlenza, et al.. (2020). 1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).

14.

Ekhlaspour, Laya, Laura M. Nally, Firas H. El-Khatib, et al.. (2019). Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Journal of Diabetes Science and Technology. 13(6). 1001–1007. 7 indexed citations

15.

Sherr, Jennifer L., Bruce A. Buckingham, Gregory P. Forlenza, et al.. (2019). Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technology & Therapeutics. 22(3). 174–184. 60 indexed citations

16.

Anderson, Stacey M., Bruce A. Buckingham, Marc D. Breton, et al.. (2019). Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. Diabetes Technology & Therapeutics. 21(6). 356–363. 46 indexed citations

17.

Forlenza, Gregory P., Bruce A. Buckingham, Mark P. Christiansen, et al.. (2019). Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(5). 265–272. 33 indexed citations

18.

Zaharieva, Dessi P., Kamuran Turksoy, Rubin Pooni, et al.. (2019). Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(6). 313–321. 90 indexed citations

19.

Bock, Martin de, Matthew N. Cooper, Adam Retterath, et al.. (2016). Continuous Glucose Monitoring Adherence. Journal of Diabetes Science and Technology. 10(3). 627–632. 14 indexed citations

20.

Ly, Trang T., Timothy W. Jones, Amanda Griffiths, et al.. (2011). Hypoglycemia Does Not Change the Threshold for Arousal from Sleep in Adolescents with Type 1 Diabetes. Diabetes Technology & Therapeutics. 14(2). 101–104. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact